Please do not fill-in this field

About
Our Work
Services & Facilities
People
Education
Careers
News & Events

Support COVID-19 Research

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

About
Our Work
- Institute Themes
- Immunology
- Antimicrobial Resistance and Healthcare Associated Infections
Services & Facilities
- Services
- Facilities
People
Education
Careers
News & Events

Support COVID-19 Research

News

16 Sep 2021

Therapeutic targeting for SARS-CoV-2 using CRISPR-Cas13

First published in the Doherty Institute Impact Report 2020

News Archive

2021
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
2020
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2019
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2018
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2017
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2016
- January
- February
- March
- April
- May
- June
- July
- August
- September
- October
- November
- December
2015
- June
- July
- August
- October
- November
- December

KEEP INFORMED

Facebook
Twitter
Instagram

Subscribe for the latest news, events and research

For any media enquiries, please contact:

Robyn Riley
Senior Media and Communications Officer
M: +61 (0) 419 255 118
E: robyn.riley@unimelb.edu.au

Rebecca Elliott
Communications Manager
T: +61 (0) 3 8344 8360
M: +61 412 103 306
E: rebecca.elliott@unimelb.edu.au

Contact Us

792 Elizabeth Street
Melbourne, 3000
Get Directions

doherty-reception@unimelb.edu.au
+61 3 9035 3555
Contact Us

Keep informed

Facebook
Twitter
Instagram
LinkedIn

Subscribe for the latest news, events and research

We acknowledge the Wurundjeri people of the Kulin Nation as the traditional custodians of the land where our Institute stands.

We are committed to collaboration with Aboriginal and Torres Strait Islander communities to reduce the unacceptable burden of infectious disease. We are committed to training the next generation of exceptional Indigenous leaders in infection and immunity.